tiprankstipranks
Advertisement
Advertisement
Aurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
PremiumThe FlyAurinia to acquire Kezar Life Sciences for $6.955 in cash per share plus CVR
5d ago
Kezar Divests Sec61 Program to Refocus on Core Pipeline
Premium
Company Announcements
Kezar Divests Sec61 Program to Refocus on Core Pipeline
23d ago
KZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
KZR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
25d ago
Kezar Life Sciences Repays Loan, Ends Agreement
PremiumCompany AnnouncementsKezar Life Sciences Repays Loan, Ends Agreement
5M ago
Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
Premium
The Fly
Kezar Life Sciences price target lowered to $5 from $7 at Wells Fargo
6M ago
Kezar downgraded to Market Perform from Outperform at William Blair
Premium
The Fly
Kezar downgraded to Market Perform from Outperform at William Blair
6M ago
Kezar Life Sciences trading resumes
PremiumThe FlyKezar Life Sciences trading resumes
6M ago
Kezar says interim study required by FDA would delay future zetomipzomib trials
Premium
The Fly
Kezar says interim study required by FDA would delay future zetomipzomib trials
6M ago
Kezar Life Sciences to explore strategic alternatives
Premium
The Fly
Kezar Life Sciences to explore strategic alternatives
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100